The Gene Editing Business: Rent Extraction in the Biotech Industry
Open Access
- 24 October 2024
- journal article
- research article
- Published by Taylor & Francis in Review of Political Economy
- p. 1-36
Abstract
No abstract availableKeywords
Funding Information
- UK Research and Innovation
- Economic and Social Research Council
- Ministério da Educação e Ciência
- Fundação para a Ciência e a Tecnologia
This publication has 133 references indexed in Scilit:
- Updates and Applications of CRISPR/Cas Technology in PlantsJournal of Plant Biology, 2023
- The CRISPR Patent Ruling and Implications for MedicineJAMA, 2023
- The principles driving gene drives for conservationEnvironmental Science & Policy, 2022
- Rent appropriation in global value chains: The past, present, and future of intangible assetsGlobal Strategy Journal, 2022
- Empowering Indigenous Knowledge in Deliberations on Gene Editing in the WildHastings Center Report, 2021
- Do firms profit from patent litigation? The contingent roles of diversification and intangible assetsResearch Policy, 2021
- Socializing the risks and rewards of public investments: Economic, policy, and legal issuesResearch Policy, 2020
- CRISPR-Cas9 Genome Editing Tool for the Production of Industrial BiopharmaceuticalsMolecular Biotechnology, 2020
- Why Include the Public in Genome Editing Governance Deliberation?AMA Journal of Ethics, 2019
- The Heroes of CRISPRCell, 2016